• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management

Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management

by Glenn S. Demby | Jun 15, 2022 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet

Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Microchip Could Lead To Home-Based Prostate Cancer Tests

New Microchip Could Lead To Home-Based Prostate Cancer Tests

by Toyohashi University of Technology | Mar 7, 2022 | Articles, News, Open Content

Associate professor Kazuhiro Takahashi and Tomoya Maeda (a second-year master’s student) and other members of the Department of Electrical and Electronic Information Engineering at Toyohashi University of Technology have developed a semiconductor sensor capable...
Study Shows Utility of Blood Test for Prostate Cancer Risk Assessment

Study Shows Utility of Blood Test for Prostate Cancer Risk Assessment

by Cleveland Diagnostics | Mar 3, 2022 | Articles, News, Open Content

CLEVELAND, OH — Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, recently announced the publication of a large real-world clinical utility study in Urology Practice, a...
Emerging Tests: New Genetic Tests May Be Better than PSA Screening in Assessing Prostate Cancer Risk

Emerging Tests: New Genetic Tests May Be Better than PSA Screening in Assessing Prostate Cancer Risk

by Glenn S. Demby | Nov 16, 2019 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, FDA-dtet

...

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com